Enzon Pharmaceuticals (STU:EZ1) Accounts Payable : €0.31 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Enzon Pharmaceuticals Accounts Payable?

Enzon Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2024 was €0.31 Mil.

Enzon Pharmaceuticals's quarterly Accounts Payable declined from Sep. 2023 (€0.32 Mil) to Dec. 2023 (€0.30 Mil) but then increased from Dec. 2023 (€0.30 Mil) to Mar. 2024 (€0.31 Mil).

Enzon Pharmaceuticals's annual Accounts Payable increased from Dec. 2021 (€0.29 Mil) to Dec. 2022 (€0.31 Mil) but then declined from Dec. 2022 (€0.31 Mil) to Dec. 2023 (€0.30 Mil).

Enzon Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Enzon Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzon Pharmaceuticals Accounts Payable Chart

Enzon Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.29

0.25

0.29

0.31

0.30

Enzon Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															0.31	0.31	0.32	0.30	0.31

Enzon Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Enzon Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Enzon Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzon Pharmaceuticals (STU:EZ1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzon Pharmaceuticals Inc (STU:EZ1) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

ENZN:USA

Address

20 Commerce Drive, Suite 135, Cranford, NJ, USA, 07016

Website

http://www.enzon.com

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company earns revenue in the form of royalties. Primary source of royalty revenues derived from the sales of PegIntron, which is marketed by Merck.

Enzon Pharmaceuticals (STU:EZ1) Headlines

No Headlines